Patient Registry for Sleep Problems in Blind Individuals

This study is creating a registry (a collection of information) about blind individuals who experience sleep problems, especially Non-24-hour sleep-wake disorder (Non-24). Non-24 is a condition where totally blind people have abnormal sleep at night and feel sleepy during the day. The study aims to better understand these sleep issues, look into possible treatments, and help recruit for future studies. You can join if you are blind and have a self-described problem with sleep or daytime sleepiness. The study collects information through a phone or web survey about your vision and sleep. The main goal is to gather information from many blind participants to learn more about these sleep conditions.

Study design
This is an observational study aiming to enroll 10,000 participants. It is not testing a specific treatment but rather collecting information.
What's involved
You would participate by completing a phone or web survey about your vision and sleep problems.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, the number of blind participants, is measured on an ongoing basis, but specific follow-up duration is not mentioned.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01195558

Patient Registry of Blind Subjects With Sleep-related Problems

Recruiting
Not specifiedAll AgesObservational
Vanda Pharmaceuticals
~10,000 participants
Updated 2020-06-24 on ClinicalTrials.gov
What's tested:Data collection on blindness and sleep problems

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of blind participants
Measured over ongoing
Sleep-wake Disorder in Blind Individuals

NCT01195558

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Vanda Pharmaceuticals

    Washington D.C., District of Columbiastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Vanda Pharmaceuticals
  • Number of blind participantsongoing